Saumya Sharma, MD
Clinical Cardiac Electrophysiology · Humble, TXNPI 1821241134
Payments from drug & device makers
Across 1,321 payments — averaging $638.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$594K
- Boston Scientific$155K
- Cook Research Incorporated$67K
- Cook Incorporated$21K
- Wilson Cook Medical Incorporated$3K
- Cook Medical LLC$2K
- plus $2K from 16 others
Across 2 payments — averaging $1606.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cook Research Incorporated$3K
What the payments were for
- Consulting fees$26,22221%
- Speaking & faculty fees$29,52524%
- Travel & lodging$6,9556%
- Food & beverage$61,30449%
- Education$1080%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 1,063 | $593,773 |
| Boston Scientific | 160 | $154,603 |
| Cook Research Incorporated | 10 | $66,763 |
| Cook Incorporated | 7 | $21,435 |
| Wilson Cook Medical Incorporated | 1 | $2,560 |
| Cook Medical LLC | 12 | $1,916 |
| Cardiva Medical, Inc. | 26 | $568 |
| Biosense Webster, Inc. | 14 | $485 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $195 |
| Cvrx, Inc. | 2 | $184 |
| Biotronik Inc. | 1 | $146 |
| Abiomed | 2 | $123 |
| AstraZeneca | 1 | $118 |
| Atricure, Inc. | 2 | $116 |
| Canon Medical Systems USA, Inc. | 3 | $99 |
| Novartis | 2 | $68 |
| Pfizer | 2 | $43 |
| Argon Medical Devices, Inc. | 2 | $30 |
| Johnson & Johnson | 1 | $21 |
| Medtronic | 1 | $20 |
| Angiodynamics, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$17,494
- Evolution$14,402
- ADVISOR$8,547
- AMPLATZER$7,921
- Cook Medical Lead Management$7,500
- Cook Medical Lead Extraction$5,920
- Advisor Catheter$5,582
- EnSite Precision Cardiac Mapping System$4,037
- AVEIR$3,089
- Angio-Seal Vascular Closure Dev$2,508
- JETi All In One Non-Sterile Kit$2,275
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$1,500
- Confirm Rx$1,274
- GALLANT$1,263
- EMBLEM$1,108
- Cook Medical Lead Management - Lead Extraction$1,106
- EnSite X$1,074
- ENSITE PRECISION$959
- AMPLATZER Occluders$844
- Ensite Cardiac Mapping System$676
How this compares
$843,298 in reported general payments places this provider in the 90th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 83 | $81,901 |
| XareltoRivaroxaban | 13 | $11,809 |
| Colchicine | 129 | $2,811 |
| Flecainide Acetate | 42 | $2,108 |
| Amiodarone Hcl | 73 | $1,697 |
| Minocycline Hcl | 204 | $1,376 |
| ClopidogrelClopidogrel Bisulfate | 136 | $1,054 |
| Metoprolol Succinate | 58 | $894 |
| Sucralfate | 132 | $887 |
| Mupirocin | 95 | $575 |
| Pantoprazole Sodium | 112 | $434 |
| Potassium Chloride | 13 | $106 |
| Carvedilol | 14 | $82 |
| Furosemide | 22 | $44 |
| Prednisone | 19 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $43 | $81,90183 claims |
| Johnson & JohnsonXarelto | $21 | $11,80913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Humble
- Andrea NataleAustin$7.8M
- George ManoukianShenandoah$3.2M
- Rodney HortonAustin$2.5M
- Stanislav WeinerLongview$2.4M
- Michael DelaughterBedford$2.1M
- James DevillePlano$1.5M
- Robert CanbyAustin$1.5M
- Amin Al-AhmadAustin$1.4M
- Theodore TakataFort Worth$1.4M
- Miguel ValderrabanoHouston$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.